Table 3.
Patient characteristics | Age |
Pre-existing liver disease | |
Hormonal treatment | |
Conditioning regimen | Cyclophosphamide |
Total body irradiation | |
Busulfan | |
Carmustine | |
Carboplatin | |
Thiotepa | |
Melphalan | |
Gemtuzumab ozogamicin | |
Transplant source | HLA-identical non-related donor |
HLA mismatch donor | |
Infection or antibiotics | Cytomegalovirus reactivation |
Amphotericin during conditioning | |
Acyclovir during conditioning | |
Vancomycin during conditioning |
LDH, lactate dehydrogenase; TLS, tumour lysis syndrome.